He is an Associate Professor of Pathology at Harvard Medical School and the Lab Director of the Tissue Typing Laboratory at Brigham and Women's Hospital (BWH) in Boston, MA. He is board-certified in Clinical Pathology, Blood Banking/Transfusion Medicine, and Clinical Informatics, and he is also an ACHI-certified HLA Lab Director. He is co-founder of the Transfusion Medicine Question of the Day. His research interests include red blood cell (RBC) and platelet (PLT) antigen genotyping. In particular, he has developed databases and websites for RBC and PLT antigen phenotype and genotype correlations, along with automated interpretive algorithms for next-generation sequencing and high-density DNA array data. He is also a strong proponent of ABO genotyping in transplantation.

Kazutoyo Osoegawa is a Research Science & Technical Lead at the Stanford Blood Center (SBC) where he has worked for 11 years. He leads various innovation projects focused on HLA in both molecular and serology, and development of tools to improve work efficacy for the clinical laboratory.

She is the histocompatibility and immunogenetics laboratory director of Southwest Immunodiagnostics, Inc. in San Antonio. She has more than 30+ years of experience in the field of Histocompatibility and Immunogenetics. Dr. Murphey has served as the chair of the UNOS Histocompatibility Committee, member of the UNOS Continuous Distribution Kidney/Pancreas Workgroup and the UNOS Kidney committee. She has published numerous papers and book chapters. She is also active in ASHI, has served on many committees including the National Clinical Affairs Committee (NCAC) and the President of ASHI. Dr. Murphey is also a member of American Transplantation Society (AST) and International Society of Heart and Lung Transplantation (ISHLT).

Marcelo Fernández-Viña, PhD, F(ACHI) is a Professor for the Department of Pathology at Stanford University Medical School and serves as Director of the Histocompatibility, Immunogenetics and Disease Profiling Laboratory at this institution. He has been working in the fields of Histocompatibility and Immunogenetics since 1982. He has more than 250 peer reviewed publications, many of them focusing on HLA variation in multiple world populations, identifying susceptibility and resistance factors for diseases. In addition his work also focus in the definition of HLA serologic and molecular mismatches in the evaluation of their impact in the outcome of allogeneic transplants. He served as expert Consultant for Donor Searches for NMDP and as President Elect, President and Past President of the American Society for Histocompatibility and Immunogenetics. He served as a member of the Board of Directors and the Executive Committee for the United Network for Organ Sharing. He served as Co-Chair of the Immunobiology Committee of the CIBMTR. He also served as a member of the HHS Advisory Council on Blood Stem Cell Transplantation (ACBSCT). He serves as HLA Expert Consultant for the NMDP for the HRSA contract and is a member of the Histocompatibility Advisory Group for NMDP. He is Councilor of the International Histocompatibility Workshop and a member of the WHO Nomenclature Committee for Factors of the HLA System and was Chairman of the (17th) International HLA & Immunogenetics Workshop, and Past President of the International HLA & Immunogenetics Workshop.